title: Secukinumab for Acrodermatitis Continua of Hallopeau.
authors.affiliation: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
authors.forename: David
authors.initials: D
authors.lastname: Muggli
authors.affiliation: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
authors.forename: Julia-Tatjana
authors.initials: JT
authors.lastname: Maul
authors.affiliation: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
authors.forename: Florian
authors.initials: F
authors.lastname: Anzengruber
authors.affiliation: Center for Laser and Aesthetic Medicine, Meilen, Switzerland.
authors.forename: Myriam Wyss
authors.initials: MW
authors.lastname: Fopp
authors.affiliation: Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
authors.forename: Alexander A
authors.initials: AA
authors.lastname: Navarini
mesh_terms: D000169:Acrodermatitis / Q000175:diagnosis / Q000188:drug therapy*; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D001706:Biopsy; D005533:Foot Dermatoses / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D012867:Skin / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C555450:secukinumab